UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000010549
Receipt No. R000012334
Scientific Title Phase II study of Temozolomide monotheraphy in patients with first line treatment-refractory neuroendocrine carcinoma
Date of disclosure of the study information 2013/04/20
Last modified on 2017/10/26 23:11:13

No. Disposal Last modified on Item of update
1 Insert 2013/04/19 20:42:13
2 Update 2014/10/24 17:26:02 Study type
Basic design
Randomization
Blinding
Control
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_1
Key exclusion criteria
3 Update 2014/10/24 17:27:15 TEL
Email
Last name of contact person
Last name of contact person
TEL
Email
4 Update 2014/12/22 19:45:17 Interventions/Control_1
5 Update 2016/09/17 10:28:20 Name of primary sponsor
Organization
6 Update 2017/04/22 15:01:36 Recruitment status
7 Update 2017/10/26 23:11:13 Recruitment status


Contact us.